RecruitingNCT06864338

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test (eAArly DETECT)


Sponsor

Mainz Biomed

Enrollment

2,700 participants

Start Date

Dec 18, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new stool-based screening test (the Mainz Biomed test) to see how well it can detect colorectal cancer and large pre-cancerous growths (called advanced adenomas) before a colonoscopy. **You may be eligible if...** - You are 45 years of age or older - You have been advised to get a routine screening colonoscopy - You are at average risk for colorectal cancer (no strong personal or family history) - You have been diagnosed with colorectal cancer or advanced adenoma and are scheduled for surgery **You may NOT be eligible if...** - You have symptoms like rectal bleeding or unexplained weight loss - You have had a colonoscopy in the past 9 years (for average risk) or 3 years (for higher risk) - You are currently pregnant - You are already enrolled in another clinical study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Virtual Research Group

Morrisville, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06864338


Related Trials